Show simple item record

dc.contributor.authorShishido, Akira
dc.contributor.authorHanna, Peter, M.D.
dc.contributor.authorEngelmann, Alexander
dc.contributor.authorKaur, Harpreet
dc.contributor.authorTalwani, Rohit
dc.date.accessioned2023-11-03T17:15:17Z
dc.date.available2023-11-03T17:15:17Z
dc.date.issued2022-05-17
dc.identifier.urihttp://hdl.handle.net/10713/21000
dc.descriptionThe article processing charges (APC) for this open access article were partially funded by the Health Sciences and Human Services Library's Open Access Publishing Fund for Early-Career Researchers.en_US
dc.description.abstractWhile the COVID-19 pandemic continues to evolve, different phenotypic variants of the disease are being recognized.Multisystem inflammatory syndrome in adults is an emerging entity that has yet to be fully characterized. The syndrome involves extrapulmonary multiorgan failure with hyperinflammation that typically affects young healthy males, approximately 2 to 12 weeks after infection with SARS-CoV-2. There are no formal guidelines for management, although the syndrome appears responsive to immunomodulators and supportive care. Clinicians should be aware of this unusual and severe clinical entity and the general principles of its management.en_US
dc.language.isoen_USen_US
dc.relation.ispartofAnnals of Internal Medicine Clinical Casesen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectmultisystem inflammatory syndromeen_US
dc.subject.meshInflammationen_US
dc.subject.meshCOVID-19en_US
dc.titleA Case of Steroid-Responsive Multisystem Inflammatory Syndrome in Adults With SARS-CoV-2en_US
dc.typeArticleen_US
refterms.dateFOA2023-11-03T17:15:18Z


Files in this item

Thumbnail
Name:
Shishido_Akira_APC_2022.pdf
Size:
355.3Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International